| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |